Evidence map›Paper›PMID 41505088›Full record

ArticleNucleic acids research2026

Junction-targeting designs limit the application of CRISPR-Cas13d in circular RNA perturbation studies.

Yannick C Lee-Yow, Raeline C Valbuena, Chiara S Richter, Howard Y Chang, Jesse M Engreitz

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yannick C Lee-YowDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94304, United States.ORCID 0000-0002-9642-9121
Raeline C ValbuenaDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94304, United States.
Chiara S RichterDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94304, United States.
Howard Y ChangDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94304, United States.
Jesse M EngreitzDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94304, United States.

Funding

GENETICS TRAINING PROGRAM FOR PHD CANDIDATEST32GM007790 · NIGMS · STANFORD UNIVERSITY · PI BRUNET, ANNE, KINGSLEY, DAVID M · 1985 to 2020
$12.8M
Mapping enhancer-gene regulation in single cells to connect genetic variants to target genes and cell typesR35HG011324 · NHGRI · STANFORD UNIVERSITY · PI ENGREITZ, JESSE M · 2020 to 2024
$2.3M
GRFP DGE-1656518Howard Hughes Medical InstituteLucile Packard Children's Hospital at Stanford UniversityNHGRI NIH HHS R35 HG011324NHGRI NIH HHS R35HG011324NIGMS NIH HHS T32 GM007790NIH HHS 5T32GM007790Novo Nordisk Foundation NNF21SA0072102Stanford Interdisciplinary Graduate Fellowship
6 · The paper itself

Abstract

Circular RNAs (circRNAs) are RNA molecules formed through the backsplicing of linear exons. Several thousand have been identified, yet relatively few are functionally characterized due to challenges in distinguishing effects of circular from linear RNA targets. Recently, CRISPR-Cas13 systems have been utilized to directly target unique junctions formed through backsplicing, potentially allowing for selective degradation of circular isoforms. Applying this approach in pooled screens has indeed identified circRNAs proposed to affect viability in several cancer cell lines. However, the design limitations of applying Cas13d to study circRNAs are not fully characterized. Here, we assessed the limitations of Cas13d-mediated circRNA knockdowns by performing essentiality screens on 900 highly expressed circRNAs in K562, an ENCODE tier 1 cell line. We observed consistent off-target knockdown of linear isoforms by certain circRNA-targeting single-guide RNAs (sgRNAs). Re-analysis of existing Cas13d screens in other cell types revealed similar off-target effects. Using machine learning models that predict Cas13d sgRNA efficacy, we further found that most circRNA-targeting sgRNAs are unlikely to induce strong knockdown. After accounting for these design constraints, 0 of 346 circRNAs testable in our screens had detectable effects on proliferation. Our findings highlight key limitations of junction-targeting strategies, with implications for future circRNA perturbation studies.

Indexed as

CRISPR-Cas SystemsRNARNA, CircularGene Knockdown TechniquesHumansK562 CellsRNA, Guide, CRISPR-Cas SystemsRNARNA, CircularRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID41505088
PMCPMC12908608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.